C20′ urea derivatives of vinca alkaloids
A vinca alkaloid compound that is substituted at the 20′-position with a urea or thiourea group is disclosed. The urea's proximal nitrogen atom bonded to the 20′-position carbon atom is secondary, whereas the distal nitrogen atom can be unsubstituted only when the compound contains an optionally present 10′-fluoro substituent, and is otherwise preferably mono- or di-substituted. Methods of preparing the compounds are disclosed as are compositions for their use and methods of treatment using a compound.
1. A vinca alkaloid compound or pharmaceutically acceptable salt thereof that is substituted at the 20′-position with a urea or thiourea group in which a proximal nitrogen atom that is directly bonded to the 20′-carbon atom is secondary and a distal nitrogen atom that is unsubstituted, or contains one or two substituents, wherein said one or two substituents are independently selected from the group consisting of a) a straight or branched chain hydrocarbyl group that has 1 to about 6 carbon atoms that is free of quaternary carbon atoms, b) an aromatic or aliphatic carbocyclic or heterocyclic ring structure that contains one or two rings, up to twelve ring atoms, and up to four ring atoms that are independently nitrogen, oxygen or sulfur, said ring structure being optionally substituted with 1, 2 or 3 substituents selected from the group consisting of C 1 -C 6 -hydrocarbyl, C 1 -C 6 -hydrocarbyloxy, phenyl, halogen, perfluoro-C 1 -C 6 -hydrocarbyl, perfluoro-C 1 -C 6 -hydrocarbyloxy, nitro and mixtures thereof, c) an aralkyl or heteroaralkyl group containing 5 or 6 ring atoms of which up to three ring atoms can independently be nitrogen, oxygen or sulfur and 1-3 carbons in the alkyl portion, said ring structure being optionally substituted with 1, 2 or 3 substituents selected from the group consisting of C 1 -C 6 -hydrocarbyl, C 1 -C 6 -hydrocarbyloxy, phenyl, halogen, perfluoro-C 1 -C 6 -hydrocarbyl, perfluoro-C 1 -C 6 -hydrocarbyloxy, nitro and mixtures thereof, and d) two substituents on the distal nitrogen atom together with that distal nitrogen atom form a single 5- or 6-membered ring or a fused ring system containing two rings, each of which can contain a 5- or 6-members and can also contain one or two additional ring hetero atoms that can independently be nitrogen, oxygen or sulfur said ring or ring system being optionally substituted with 1, 2 or 3 substituents selected from the group consisting of C 1 -C 6 -hydrocarbyl, C 1 -C 6 -hydrocarbyloxy, phenyl, halogen, perfluoro-C 1 -C 6 -hydrocarbyl, perfluoro-C 1 -C 6 -hydrocarbyloxy, nitro and mixtures thereof,
said vinca alkaloid compound optionally containing a 10′-fluoro substituent and having a distal nitrogen atom that is unsubstituted only when said 10′-fluoro substituent is present.
2. The vinca alkaloid compound or salt thereof according to claim 1 that is a 20′-substituted vinblastine, vincristine or vindesine.
3. The vinca alkaloid compound or salt thereof according to claim 1 whose 20′-substituent is a urea.
4. The vinca alkaloid compound or salt thereof according to claim 3 whose distal urea nitrogen atom contains one substituent.
5. The vinca alkaloid compound or salt thereof according to claim 4 whose one substituent is a straight or branched chain hydrocarbyl group that has 1 to about 6 carbon atoms.
6. The vinca alkaloid compound or salt thereof according to claim 4 whose one substituent is an aromatic or aliphatic carbocyclic or heterocyclic ring structure that contains one or two rings, up to twelve ring atoms, and up to four ring atoms that are independently nitrogen, oxygen or sulfur.
7. The vinca alkaloid compound or salt thereof according to claim 6 whose one substituent is an aliphatic carbocyclic ring structure containing one ring containing 3-6 carbons.
8. The vinca alkaloid compound or salt thereof according to claim 6 whose one substituent is an aromatic ring structure that contains one or two rings.
9. The vinca alkaloid compound or salt thereof according to claim 8 whose aromatic ring structure contains a single substituent group.
10. The vinca alkaloid compound or salt thereof according to claim 3 , wherein two substituents on the distal urea nitrogen atom together with that distal nitrogen atom form a single 5- or 6-membered ring or a fused ring system containing two rings, each of which can contain a 5- or 6-members and can also contain one or two additional ring hetero atoms that can independently be nitrogen, oxygen or sulfur, said ring or ring system being optionally substituted with 1, 2 or 3 substituents selected from the group consisting of C 1 -C 6 -hydrocarbyl, C 1 -C 6 -hydrocarbyloxy, phenyl, halogen, perfluoro-C 1 -C 6 -hydrocarbyl, perfluoro-C 1 -C 6 -hydrocarbyloxy, nitro and mixtures thereof.
11. The vinca alkaloid compound or salt thereof according to claim 10 , wherein said two substituents on the distal urea nitrogen atom together with that distal nitrogen atom form a 6-membered ring.
12. The vinca alkaloid compound or salt thereof according to claim 10 , wherein said two substituents on the distal urea nitrogen atom together with that distal nitrogen atom form a 5-membered ring.
13. The vinca alkaloid compound or salt thereof according to claim 10 , wherein said two substituents on the distal urea nitrogen atom together with that distal nitrogen atom form a fused ring system containing two rings, each of which can contain a 5- or 6-members and can also contain one or two additional ring hetero atoms that can independently be nitrogen, oxygen or sulfur.
14. The vinca alkaloid compound or salt thereof according to claim 1 that corresponds in structure to Formula I below:
I
R 1
R 2
R 3
Vinblastine (1)
—CH 3
Vincristine (2)
Vindesine (1a)
—CH 3
—OH
where Z is H or F,
Y is O or S, and
R 4 and R 5 are independently selected from the group consisting of hydrido, or a) a straight or branched chain hydrocarbyl group that has 1 to about 6 carbon atoms that is free of tertiary or quaternary carbon atoms, b) an aromatic or aliphatic carbocyclic or heterocyclic ring structure that contains one or two rings, up to twelve ring atoms, and up to four ring atoms that are independently nitrogen, oxygen or sulfur, said ring structure being optionally substituted with 1, 2 or 3 substituents selected from the group consisting of C 1 -C 6 -hydrocarbyl, C 1 -C 6 -hydrocarbyloxy, phenyl, halogen, perfluoro-C 1 -C 6 -hydrocarbyl, perfluoro-C 1 -C 6 -hydrocarbyloxy, nitro and mixtures thereof, c) an aralkyl or heteroaralkyl group containing 5 or 6 ring atoms of which up to three ring atoms can independently be nitrogen, oxygen or sulfur and 1-3 carbons in the alkyl portion, said ring structure being optionally substituted with 1, 2 or 3 substituents selected from the group consisting of C 1 -C 6 -hydrocarbyl, C 1 -C 6 -hydrocarbyloxy, phenyl, halogen, perfluoro-C 1 -C 6 -hydrocarbyl, perfluoro-C 1 -C 6 -hydrocarbyloxy, nitro and mixtures thereof, and d) two substituents on the distal nitrogen atom together with that distal nitrogen atom form a single 5- or 6-membered ring or a fused ring system containing two rings, each of which can contain a 5- or 6-members and can also contain one or two additional ring hetero atoms that can independently be nitrogen, oxygen or sulfur said ring or ring system being optionally substituted with 1, 2 or 3 substituents selected from the group consisting of C 1 -C 6 -hydrocarbyl, C 1 -C 6 -hydrocarbyloxy, phenyl, halogen, perfluoro-C 1 -C 6 -hydrocarbyl, perfluoro-C 1 -C 6 -hydrocarbyloxy, nitro and mixtures thereof,
with the proviso that R 4 and R 5 are only both hydrido when Z is F.
15. The vinca alkaloid compound or salt thereof according to claim 14 , wherein Z is F.
16. The vinca alkaloid compound or salt thereof according to claim 15 that corresponds in structure to the structural formula below.
17. A pharmaceutical composition that comprises a cancerous cell proliferation-inhibiting amount of a 20′-urea-substituted vinca alkaloid compound of claim 1 or a pharmaceutically acceptable salt thereof dissolved or dispersed in a physiologically acceptable carrier.
18. A method of inhibiting the growth of cancerous cells that comprises contacting said cancerous cells with a cancerous cell proliferation-inhibiting amount of a 20′-urea- or thiourea-substituted vinca alkaloid compound of claim 1 or a pharmaceutically acceptable salt thereof.
19. The method according to claim 18 , wherein said cancerous cells are contacted a plurality of times.
20. The method according to claim 18 , wherein said cancerous cells are contacted in vitro.
21. The method according to claim 18 , wherein said contacted cancerous cells are leukemia cells.
22. The method according to claim 18 , wherein said contacted cancerous cells are carcinoma cells.
23. The method according to claim 22 , wherein said contacted carcinoma cells are resistant to vinblastine.